Table 2.
Outcome | Multivariate prevalence, OR | 95% CI |
---|---|---|
Lobular versus ductal carcinoma | ||
Age at cancer diagnosis | 1.07 | 1.01–1.14 |
SLE duration | 0.99 | 0.90–1.08 |
Calendar period | 0.56 | 0.11–2.88 |
Special subtypes versus ductal carcinoma | ||
Age at cancer diagnosis | 1.06 | 1.01–1.10 |
SLE duration | 1.05 | 1.00–1.11 |
Calendar period | 0.60 | 0.18–2.05 |
Two outcomes were modeled: lobular versus ductal breast cancer and special histological subtypes versus ductal cancer (n = 120). Each model included the three variables listed. Age was a continuous variable. SLE duration was assessed at cancer diagnosis, categorical (≤5 years’, 5–10 years’, and >10 years’ duration). Calendar year period in which cancer occurred was dichotomized (≤1990 and >1990).